Article info

Download PDFPDF
Original research
Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation

Authors

  1. Correspondence to Professor Jürg Hans Beer, Department of Medicine, Cantonal Hospital of Baden, Baden Cantonal Hospital, Baden, 5404, Switzerland; hansjuerg.beer{at}ksb.ch
View Full Text

Citation

Luciani M, Müller D, Vanetta C SWISS-AF Investigators, et al
Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation

Publication history

  • Received May 16, 2022
  • Accepted November 17, 2022
  • First published January 2, 2023.
Online issue publication 
February 14, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.